OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel ...

A fireside chat at the Stifel Targeted Oncology Forum, which will be held virtually April 8-9, 2025. Additional information will be available on the OnKure website. About OnKure Therapeutics ...

In a report released on February 23, Shlomo Rosenbaum from Stifel Nicolaus maintained a Buy rating on UL Solutions Inc. Class A (ULS – Research ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Andrew Nicholas, William Blair ... including technology and life sciences. David Grossman, Stifel: Asked about ASO growth potential and broker channel penetration. Simonds highlighted plans ...

Stifel Nicolaus dropped their price target on ... In other news, insider Nicholas Daniel sold 1,500 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was ...

Nicholas Investment Partners LP increased its ... rating for the company in a report on Thursday, October 31st. Stifel Nicolaus increased their price objective on shares of Microsoft from $475. ...

Etsy's stock fell 5.4% on Wednesday, trading as low as $44.48 before closing at $44.32. Analysts have recently adjusted their ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...